Weight Loss

Reta (GLP-3) (Reconstituted) - 60mg

Reconstituted at 60mg / 2mL

Reconstituted at 60mg / 2mL

Reta (GLP-3) (Reconstituted) - 60mg Default

Reta (GLP-3) (Reconstituted) - 60mg — Default

Reconstituted at 60mg / 2mL

$500/mo

References

  1. Reta (GLP-3) (Reconstituted) - 60mg - Peptide Center guide
  2. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialThe New England journal of medicine, 2023
  3. Retatrutide-A Game Changer in Obesity PharmacotherapyBiomolecules, 2025
  4. Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trialsDiabetes, obesity & metabolism, 2026
  5. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USALancet (London, England), 2023
  6. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialNature medicine, 2024
  7. The power of three: Retatrutide's role in modern obesity and diabetes therapyEuropean journal of pharmacology, 2024

Ready to start with Reta (GLP-3) (Reconstituted) - 60mg?

Take our eligibility quiz to see if this treatment is right for you.

Start Intake